Major Scope

  •  Cardiovascular Case Reports
  •  Oncology Case Reports
  •  Surgical Case Reports
  •  Gastroenterological Case Reports
  •  Neurological Case Reports
  •  Dermatological Case Reports
  •  Respiratory Case Reports
  •  Obstetrics/Gynecology Case Reports
  •  Nephrology Case Reports
  •  Immunology Case Reports
  •  Paediatric Case Reports
  •  Orthopedics Case Reports
  •  Dental Case Reports

Abstract

Citation: Ann Clin Case Rep. 2025;10(1):2765.DOI: 10.25107/2474-1655.2765

When the Heart Talks to the Brain: Rethinking Cardiovascular-Neurodegenerative Interfaces

Jin Ju* and Zhiguo Wang*

1Department of Pharmacy, the First Affiliated Hospital of Jinan University, Guangzhou 510630, China 2Guangdong Provincial Key Laboratory for Chronic Disease Interactive Network Research, Jinan University, Guangzhou 510632, China

*Correspondance to: Zhiguo Wang 

 PDF  Full Text Case Report | Open Access

Abstract:

Emerging research reveals a bidirectional interface between cardiovascular diseases—such as atrial fibrillation (AF) and heart failure (HF)—and neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). While traditional models have emphasized shared risk factors such as aging, chronic inflammation, and metabolic dysfunction, newer evidence points to a more dynamic and causative framework: a reciprocal interactome composed of signaling molecules, extracellular vehicles, and neurohormonal circuits linking cardiac and cerebral systems. Cardiokines (e.g., natriuretic peptides, FGF21), neurokines (e.g., BDNF, NGF), exosomes carrying noncoding RNAs, and systemic axes such as the renin–angiotensin–aldosterone system (RAAS) and hypothalamic–pituitary–adrenal (HPA) axis act as molecular bridges that mediate cross-organ communication. This review shifts focus from risk association to causative molecular dialogue, demonstrating how these interactomes drive remodeling, dysfunction, and progressive degeneration in both systems and repositions the heart–brain axis as a site of active disease–disease interaction, where reciprocal complications emerge from disrupted signaling rather than isolated end-organ pathology. Three clinical vignettes are presented to illustrate the translational relevance of this model. We propose that therapeutic strategies targeting these inter-organs signaling networks— rather than treating individual organ dysfunction in isolation—may offer a more effective and systems-level approach to managing age-related syndromes.

Keywords:

Cardiovascular diseases; Neurodegenerative disorders; Atrial fibrillation; Heart failure; Alzheimer’s disease; Parkinson’s disease; Interactomes; Cardiokines; Neurokines; Exosomes

Cite the Article:

Ju J, Wang Z. When the Heart Talks to the Brain: Rethinking Cardiovascular- Neurodegenerative Interfaces. Ann Clin Case Rep. 2025; 10: 2765..

Journal Basic Info

  • Impact Factor: 5.253*
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
  • PubMed NLM ID: 101702800

Search Our Journal

Journal Indexed In

Articles in PubMed

A New Minimally Invasive Procedure for Muscle, Back, Neck Pain and Radiculopathy - The Myofascial Nerve Block
 PubMed  PMC  PDF  Full Text
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Lobular Carcinoma In Situ within Fibroadenoma: A Case Report and Literature Review
 Abstract  PDF  Full Text
A New Method of SARS-CoV-2 Screening for Pregnant Women Based on Non-Invasive Prenatal Test
 Abstract  PDF  Full Text
View More...